umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Natalizumab Reduces Fatigue as Measured by the Fatigue Scale for Motor and Cognitive Functions (FSMC) - First Results from the TYNERGY Trial
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience, Clinical Neuroscience.
Show others and affiliations
2012 (English)In: Neurology, ISSN 0028-3878, E-ISSN 1526-632X, Vol. 78, no Suppl 1, P07081- p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Philadelphia: Lippincott Williams & Wilkins, 2012. Vol. 78, no Suppl 1, P07081- p.
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:umu:diva-55527ISI: 000303204804193OAI: oai:DiVA.org:umu-55527DiVA: diva2:528623
Conference
64th Annual Meeting of the American-Academy-of-Neurology (AAN), APR 21-28, 2012, New Orleans, LA
Available from: 2012-05-28 Created: 2012-05-21 Last updated: 2017-12-07Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Svenningsson, Anders

Search in DiVA

By author/editor
Svenningsson, Anders
By organisation
Clinical Neuroscience
In the same journal
Neurology
Neurosciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 83 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf